Western Standard LLC’s BioTelemetry, Inc. BEAT Stock Holding History

Western Standard LLC’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,800	Closed	-$1.5M	–	37
2020 Q4	$1.5M	Buy	+20,800	New	+$1.09M	1.71%	23

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Western Standard LLC's BEAT Position: Q1 2021 in Review

Western Standard LLC sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 20,800 shares — an estimated $1.5M sold.

Western Standard LLC first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $1.5M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Western Standard LLC reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Western Standard LLC sold 20,800 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.5M.
Western Standard LLC first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Western Standard LLC's BioTelemetry, Inc. position peaked at $1.5M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Western Standard LLC's 13F filing for Q1 2021, filed 17 May 2021.